659 related articles for article (PubMed ID: 32389340)
21. Louis K. Dahl Memorial Lecture. Renal and cardiovascular mechanisms of hypertension in obesity.
Hall JE
Hypertension; 1994 Mar; 23(3):381-94. PubMed ID: 8125566
[TBL] [Abstract][Full Text] [Related]
22. Hyperinsulinemia or increased sympathetic drive as links for obesity and hypertension.
Modan M; Halkin H
Diabetes Care; 1991 Jun; 14(6):470-87. PubMed ID: 1864220
[TBL] [Abstract][Full Text] [Related]
23. Cellular calcium and magnesium metabolism in the pathophysiology and treatment of hypertension and related metabolic disorders.
Resnick LM
Am J Med; 1992 Aug; 93(2A):11S-20S. PubMed ID: 1387762
[TBL] [Abstract][Full Text] [Related]
24. Insulin resistance and the sympathetic nervous system.
Egan BM
Curr Hypertens Rep; 2003 Jun; 5(3):247-54. PubMed ID: 12724058
[TBL] [Abstract][Full Text] [Related]
25. [Insulin resistance syndrome].
Murakami H; Shimamoto K
Nihon Rinsho; 2001 May; 59(5):853-9. PubMed ID: 11391982
[TBL] [Abstract][Full Text] [Related]
26. Role of the sympathetic adrenal system in the pathogenesis of the insulin resistance syndrome.
Landsberg L
Ann N Y Acad Sci; 1999 Nov; 892():84-90. PubMed ID: 10842654
[TBL] [Abstract][Full Text] [Related]
27. Mechanisms and treatment of obesity-related hypertension-Part 1: Mechanisms.
Parvanova A; Reseghetti E; Abbate M; Ruggenenti P
Clin Kidney J; 2024 Jan; 17(1):sfad282. PubMed ID: 38186879
[TBL] [Abstract][Full Text] [Related]
28. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
29. Hyperinsulinemia superimposed on insulin resistance does not elevate blood pressure.
Verma S; Leung YM; Yao L; Battell M; Dumont AS; McNeill JH
Am J Hypertens; 2001 May; 14(5 Pt 1):429-32. PubMed ID: 11368463
[TBL] [Abstract][Full Text] [Related]
30. Obesity, kidney dysfunction, and inflammation: interactions in hypertension.
Hall JE; Mouton AJ; da Silva AA; Omoto ACM; Wang Z; Li X; do Carmo JM
Cardiovasc Res; 2021 Jul; 117(8):1859-1876. PubMed ID: 33258945
[TBL] [Abstract][Full Text] [Related]
31. Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension.
Sowers JR; Whaley-Connell A; Epstein M
Ann Intern Med; 2009 Jun; 150(11):776-83. PubMed ID: 19487712
[TBL] [Abstract][Full Text] [Related]
32. Obesity hypertension, salt sensitivity and insulin resistance.
Rocchini AP
Nutr Metab Cardiovasc Dis; 2000 Oct; 10(5):287-94. PubMed ID: 11213538
[TBL] [Abstract][Full Text] [Related]
33. Sodium and obesity in the pathogenesis of hypertension.
Reisin E
Am J Hypertens; 1990 Feb; 3(2):164-7. PubMed ID: 2155002
[TBL] [Abstract][Full Text] [Related]
34. Control of metabolic and cardiovascular function by the leptin-brain melanocortin pathway.
do Carmo JM; da Silva AA; Dubinion J; Sessums PO; Ebaady SH; Wang Z; Hall JE
IUBMB Life; 2013 Aug; 65(8):692-8. PubMed ID: 23847053
[TBL] [Abstract][Full Text] [Related]
35. Hyperinsulinemia, insulin resistance, and hypertension.
Bönner G
J Cardiovasc Pharmacol; 1994; 24 Suppl 2():S39-49. PubMed ID: 7898093
[TBL] [Abstract][Full Text] [Related]
36. Obesity, cardiometabolic syndrome, and chronic kidney disease: the weight of the evidence.
Lastra G; Manrique C; Sowers JR
Adv Chronic Kidney Dis; 2006 Oct; 13(4):365-73. PubMed ID: 17045222
[TBL] [Abstract][Full Text] [Related]
37. Insulin resistance, hyperinsulinemia, and coronary artery disease: a complex metabolic web.
DeFronzo RA
J Cardiovasc Pharmacol; 1992; 20 Suppl 11():S1-16. PubMed ID: 1284137
[TBL] [Abstract][Full Text] [Related]
38. Insulin resistance, hyperinsulinemia and hypertension.
Weidmann P; de Courten M; Böhlen L
J Hypertens Suppl; 1993 Dec; 11(5):S27-38. PubMed ID: 8158379
[TBL] [Abstract][Full Text] [Related]
39. Hypertension as a Metabolic Disorder and the Novel Role of the Gut.
Tanaka M; Itoh H
Curr Hypertens Rep; 2019 Jun; 21(8):63. PubMed ID: 31236708
[TBL] [Abstract][Full Text] [Related]
40. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease.
DeFronzo RA; Ferrannini E
Diabetes Care; 1991 Mar; 14(3):173-94. PubMed ID: 2044434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
